A federal judge has overturned a $176.5 million jury verdict against Eli Lilly and Co., finding that the Indianapolis-based drugmaker did not infringe on the patents of a competitor in developing a treatment for migraine headaches.
Eli Lilly and Co. has filed lawsuits against 10 companies it accuses of selling unauthorized versions of its diabetes drug Mounjaro, Bloomberg News reported Tuesday.
Lilly, Novo Nordisk sued for alleged failure to warn about ‘severe’ side effects of popular diabetes drugs
Eli Lilly and Co. and the maker of diabetes drug Ozempic are being sued in federal court in Louisiana for allegedly failing to warn consumers and physicians about the risk of “severe gastrointestinal events” resulting from the use of two diabetes drugs.
The Supreme Court on Thursday unanimously revived whistleblower lawsuits claiming that supermarket and pharmacy chains SuperValu and Safeway overcharged government health care programs for prescription drugs by hundreds of millions of dollars.
A federal court ruling cleared the way Tuesday for OxyContin maker Purdue Pharma’s settlement of thousands of legal claims over the toll of opioids.
A pharmacist convicted of producing and distributing adulterated drugs was not entitled to attorney fees in his case against the Indiana Board of Pharmacy, which was entitled to immunity, the Court of Appeals of Indiana has ruled.
The U.S. Food and Drug Administration on Wednesday approved selling the leading version of naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold over the counter.
Indiana has reached a $66.5 million settlement with St. Louis-based health insurer Centene Corp. to resolve allegations that the company overcharged the state’s Medicaid program for pharmaceutical costs.
CVS and Walgreens have agreed to pay state and local governments a combined total of more than $10 billion to settle lawsuits over the toll of opioids and now want to know by Dec. 31 whether states are accepting the deals.
Walmart proposed a $3.1 billion legal settlement Tuesday over the toll of powerful prescription opioids sold at its pharmacies.
CVS Health and Walgreen Co. announced agreements in principle Wednesday to pay about $5 billion each to settle lawsuits nationwide over the toll of opioids, and a lawyer said Walmart is in discussions for a deal.
A federal judge ruled Wednesday that required coverage of an HIV prevention drug under the Affordable Care Act violates a Texas employer’s religious beliefs and undercut the broader system that determines which preventive drugs are covered in the U.S.
An Illinois jury has ordered Indianapolis-based Eli Lilly and Co. to pay $61 million in damages in a lawsuit filed eight years ago by a whistleblower who said the company made false claims about rebates to the federal Medicaid program.
The local subsidiary of West Lafayette-based pharmaceutical testing company Inotiv Inc. has reached a settlement with the U.S. Department of Justice and the U.S. Department of Agriculture, the company announced Monday.
The U.S. Supreme Court said Wednesday that the federal government improperly lowered drug reimbursement payments to hospitals and clinics that serve low-income communities, a reduction that cost the facilities billions of dollars.
Former Vincennes police chief arrested for stealing from department, wife arrested for theft of prescription drugs
Former Vincennes Police Department Chief Dustin Luking was arrested on multiple felony charges Wednesday for allegedly stealing thousands of dollars from an evidence vault for personal use. Also today, Bethany J. Shelton Luking, Dustin’s wife, was arrested for allegedly stealing prescription medication from her employer, a senior center in Vincennes.
The effort to hold drug companies, pharmacies and distributors accountable for their role in the opioid crisis has led to a whirlwind of legal activity around the U.S. that can be difficult keep tabs on.
A jury’s finding this week that three major pharmacy chains are responsible for contributing to the scourge of opioid addiction in two Ohio counties may be just the beginning of a protracted legal battle that ultimately could leave the communities no better off.
The federal government’s assertion that Eli Lilly and Co. violated a program to offer low-income Medicaid and Medicare patients discounted drugs was tossed by the U.S. District Court for the Southern District of Indiana in a 65-page opinion, which also hinted that Congress needs to address the problems with the 340B Drug Pricing Program.
With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson & Johnson vaccine wait anxiously to learn when it’s their turn.